FDA DrugsClass II
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetami...
Published: July 8, 2026Recall ID: D-0660-2026Category: drugsCountry: US
Reason for Recall / Hazard
Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
Product Description & Identification
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, Rx Only, 100 capsules, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC: 0527-0790-37.
Additional Source Details
| Field | Value |
|---|---|
| City | Seymour |
| State | IN |
| Event id | 99319 |
| Address 1 | 1101 C Ave W |
| Address 2 | N/A |
| Code info | Lot#: 25285401A, Exp. Date: 04/2027 |
| Postal code | 47274-3342 |
| Report date | 20260708 |
| Product type | Drugs |
| Product quantity | 1392 bottles |
| Reason for recall | Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules. |
| Voluntary mandated | Voluntary: Firm initiated |
| Recall initiation date | 20260626 |
| Initial firm notification | Letter |
| Center classification date | 20260702 |
Overview
- Recalling FirmLannett Company Inc.
- StatusOngoing
- Risk LevelClass II
- DistributionUS Nationwide.